Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 251 publications
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale.
Journal: Contemporary clinical trials
Published: May 20, 2026
Decisional incentive sensitivity is linked to contingency management outcome and striatal dopamine signaling in individuals with cocaine use disorder: a preliminary study.
Journal: Addiction and substance abuse
Published: April 20, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.
Journal: Substance use & misuse
Published: April 03, 2026
Research Ethics in Stopping Opioid Use Disorder Medication.
Journal: JAMA psychiatry
Published: March 18, 2026
Beneficial effects of the rapid vs. standard procedure for injection naltrexone initiation operate through increased adjunctive medication use.
Journal: Drug and alcohol dependence
Published: February 10, 2026
Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone.
Journal: The American journal of drug and alcohol abuse
Published: December 16, 2025
Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?
Journal: AJPM focus
Published: October 02, 2025
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone.
Journal: Journal of addiction medicine
Published: August 12, 2025
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Journal: Journal of substance use and addiction treatment
Published: July 24, 2025
Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone.
Journal: The American journal of drug and alcohol abuse
Published: July 11, 2025
The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study.
Journal: Addiction (Abingdon, England)
Published: June 20, 2025
Last Updated: 09/26/2026